Overview
- 24 inspections across 22 sites are on record.
- 52 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-05-19.
At a glance
Inspections
24
Sites
22
Observations
52
Career since
Dec 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Cambrex Profarmaco Milano Srl | 19 May 2017 | Human Drugs | On file |
| Kenvue Brands LLC | 9 Dec 2016 | Human Drugs | |
| Kenvue Brands LLC | 14 Aug 2015 | Human Drugs | |
| Frontida BioPharm Inc | 25 Jul 2014 | Human Drugs | View 483 → |
| Albhades Provence | 18 Dec 2012 | On file |
Sites inspected
Cambrex Profarmaco Milano SrlPaullo, Italy1 insp.
Kenvue Brands LLCFort Washington, United States2 insp.
Frontida BioPharm IncPhiladelphia, United States1 insp.
Albhades ProvenceOraison, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Vlada Matusovsky4 shared
Francis A Guidry3 shared
James C Maclaughlin3 shared
Megan A Haggerty3 shared
Mark R Mcclain3 shared
Thomas E Friel2 shared
Denise M Digiulio2 shared
Matthew R Noonan2 shared
Sam Pepe2 shared
Margaret M Annes1 shared
Full investigator report
Get the verbatim findings behind Temar Q Williams' 52 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site